Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01605630 · ClinicalTrials.gov registry record · Phase 1

Family Cancer Literacy to Promote Mammography Screening Among Navajo Women

A Phase 1 study, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target

NCT01605630: Completed Phase 1 study, sponsored by Mayo Clinic.

NCT01605630 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01605630, a Phase 1 study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target

Study Summary

The no show rate for mammography screening is high among Navajo women. One barrier to preventive screening is a lack of cancer literacy including low knowledge and cultural attitudes (e.g., fatalism) about screening. The investigators will examine the potential feasibility and acceptability of a cancer literacy intervention for families of Navajo women who have no showed for three consecutive times to mammography screening who have never or rarely been screened in the past.

Primary Outcome

Participants will be asked if they found the intervention to be helpful or not and if they would recommend it to other women

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Family-based family cancer literacy intervention

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-03
Est. Completion 2017-12
Phase Phase 1
Mayo Clinic

2,844 total trials

What the finished NCT01605630 record still lists

NCT01605630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% lower).

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT01605630 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01605630 about?

NCT01605630 is a clinical study titled "Family Cancer Literacy to Promote Mammography Screening Among Navajo Women". The no show rate for mammography screening is high among Navajo women. One barrier to preventive screening is a lack of cancer literacy including low knowledge and cultural attitudes (e.g., fatalism) about screening. The investigators will examine the potential feasibility and acceptability of a can...

What is the current status of trial NCT01605630?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2012-03. Estimated completion is 2017-12.

What interventions are being tested in trial NCT01605630?

The interventions under investigation include: Control (BEHAVIORAL), Family-based family cancer literacy intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01605630?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01605630's enrollment target sits among peer trials

40 1130th of 2000 higher than 810 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01605630, the US trial registry maintained by the National Library of Medicine. NCT01605630 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.